BioSymetrics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.06M
BioSymetrics General Information
Description
Developer of a biomedical artificial intelligence platform designed to provide disease understanding and personalized drugs. The company's platform performs predictive analytics on research and healthcare data used in pharmaceutical research, and accelerates early-stage drug discovery, enabling biopharmaceutical researchers, hospitals, and health systems to build a comprehensive view of human health.
Contact Information
Website
www.biosymetrics.com(Operating Subsidiary)
Corporate Office
- 315 Main Street, 2nd floor
- Huntington
- New York, NY 11743
- United States
Corporate Office
- 315 Main Street, 2nd floor
- Huntington
- New York, NY 11743
- United States
BioSymetrics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 08-Apr-2025 | $6.06M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Seed Round | 04-Aug-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 11-Sep-2018 | $3.85M | $3.85M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue |
BioSymetrics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
BioSymetrics Comparisons
Industry
Financing
Details
BioSymetrics Competitors (6)
One of BioSymetrics’s 6 competitors is Valo, a Venture Capital-Backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Valo | Venture Capital-Backed | Lexington, MA | ||||
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong | ||||
| insitro | Venture Capital-Backed | South San Francisco, CA | ||||
| BenevolentAI | Formerly PE-Backed | Luxembourg, Luxembourg | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom |
BioSymetrics Patents
BioSymetrics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240161001-A1 | Data processing pipeline and platform for zebrafish phenotyping | Pending | 15-Nov-2022 | ||
| US-20250182848-A1 | Methods, systems, and frameworks for gene disease prioritization in drug discovery | Pending | 15-Nov-2022 | ||
| US-12369861-B2 | Methods, systems, and frameworks for debiasing data in drug discovery predictions | Active | 03-Jun-2022 | ||
| US-20230389878-A1 | Methods, systems, and frameworks for debiasing data in drug discovery predictions | Active | 03-Jun-2022 | ||
| US-11379757-B2 | Methods, systems, and frameworks for data analytics using machine learning | Active | 31-Jul-2019 | G16H50/70 |
BioSymetrics Signals
BioSymetrics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AI Venture Labs | Accelerator/Incubator | Minority | ||
| AJI Capital | Venture Capital | Minority | ||
| Dasein Capital | Venture Capital | Minority | ||
| Mogility Capital | Venture Capital | Minority | ||
| NVIDIA GPU Ventures | Corporate Venture Capital | Minority |
BioSymetrics FAQs
-
When was BioSymetrics founded?
BioSymetrics was founded in 2017.
-
Where is BioSymetrics headquartered?
BioSymetrics is headquartered in New York, NY.
-
What is the size of BioSymetrics?
BioSymetrics has 13 total employees.
-
What industry is BioSymetrics in?
BioSymetrics’s primary industry is Decision/Risk Analysis.
-
Is BioSymetrics a private or public company?
BioSymetrics is a Private company.
-
What is the current valuation of BioSymetrics?
The current valuation of BioSymetrics is .
-
What is BioSymetrics’s current revenue?
The current revenue for BioSymetrics is .
-
How much funding has BioSymetrics raised over time?
BioSymetrics has raised $6.58M.
-
Who are BioSymetrics’s investors?
AI Venture Labs, AJI Capital, Dasein Capital, Mogility Capital, and NVIDIA GPU Ventures are 5 of 6 investors who have invested in BioSymetrics.
-
Who are BioSymetrics’s competitors?
Valo, InSilico Medicine Cayman, insitro, BenevolentAI, and Exscientia are some of the 6 competitors of BioSymetrics.
-
When was BioSymetrics acquired?
BioSymetrics was acquired on 08-Apr-2025.
-
Who acquired BioSymetrics?
BioSymetrics was acquired by Lunai Bioworks.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process